More recently, MM cell dependency on GCN2 has been linked to oncogenic MYC signaling (51), and observations that amino acid depletion sensitizes MM cells to proteasome inhibition by inducing compound mitochondria damage (52) provide further evidence for complex metabolic processes linked to proteasome inhibitors. Here, MYC is linked to Miyoshi myopathy.